Artal Group S.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$977,000
-71.2%
100,0000.0%0.03%
-64.5%
Q3 2021$3,398,000
-53.6%
100,000
-50.0%
0.08%
-49.0%
Q2 2021$7,322,000
-18.4%
200,0000.0%0.15%
-5.7%
Q1 2021$8,968,000
-68.6%
200,000
-60.0%
0.16%
-74.2%
Q4 2020$28,535,000
-7.3%
500,000
-16.7%
0.61%
-17.9%
Q3 2020$30,780,000
-20.7%
600,000
-7.7%
0.75%
-31.2%
Q2 2020$38,818,000
+17.9%
650,000
-18.8%
1.09%
-22.0%
Q1 2020$32,936,000
+111.7%
800,000
+220.0%
1.39%
+131.6%
Q4 2019$15,560,000
-8.3%
250,000
-50.0%
0.60%
-11.6%
Q3 2019$16,970,000500,0000.68%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$11,213,0005.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,580,456$51,731,0001.16%
ARMISTICE CAPITAL, LLC 5,836,000$54,100,0001.05%
Pinz Capital Management, LP 165,835$1,537,0000.96%
Sunesis Advisors, LLC 96,299$893,0000.52%
Redmile Group, LLC 664,817$6,163,0000.19%
PDT Partners, LLC 222,343$2,061,0000.18%
Bayesian Capital Management, LP 41,900$388,0000.06%
Laurion Capital Management LP 459,290$4,258,0000.05%
Hennion & Walsh Asset Management, Inc. 101,643$942,0000.05%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders